Home › Funds › AlpenGlobal Capital LLC › IBB
AlpenGlobal Capital LLC position in IBB
ISHARES TR BIOTECHNOLOGY ETF
AlpenGlobal Capital LLC reported holding 3,612 shares of IBB (ISHARES TR BIOTECHNOLOGY ETF) in its Q3 2026 13F filing — a position valued at US$760K, representing 0.49% of its reported portfolio and ranking #32 among its reported holdings. AlpenGlobal Capital LLC first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How AlpenGlobal Capital LLC's IBB position evolved
AlpenGlobal Capital LLC first disclosed a stake in IBB in Q3 2026 at 3,612 shares (US$760K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 3.61K | $760.43K | New |
About IBB and 13F data
IBB (ISHARES TR BIOTECHNOLOGY ETF) is a company whose sector is not yet classified in our data. 22 other funds we track also report a position in IBB — the largest reported positions include Citigroup Inc (US$905.4M), BNP PARIBAS FINANCIAL MARKETS (US$421.8M), Two Sigma Investments (US$302.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBB
- Citigroup Inc 4.76M sh · $905.44M · Q2 2026
- BNP PARIBAS FINANCIAL MARKETS 2.22M sh · $421.83M · Q2 2026
- Two Sigma Investments 1.59M sh · $302.04M · Q2 2026
- COMMERCE BANK 909.32K sh · $172.94M · Q2 2026
- WestEnd Advisors, LLC 655.85K sh · $124.74M · Q2 2026
- Jefferies Financial Group Inc. 302.31K sh · $57.50M · Q2 2026
More on AlpenGlobal Capital LLC
FAQ
How long has AlpenGlobal Capital LLC held IBB?
AlpenGlobal Capital LLC has disclosed IBB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is AlpenGlobal Capital LLC's current position in IBB?
As of Q3 2026, AlpenGlobal Capital LLC holds 3.61K shares of IBB (ISHARES TR BIOTECHNOLOGY ETF), valued at $760.43K, representing 0.49% of its reported portfolio and ranking #32.
Has AlpenGlobal Capital LLC been buying or selling IBB?
In the latest 13F filing (Q3 2026), AlpenGlobal Capital LLC newly opened its position in IBB.
Which other funds hold IBB?
Other major institutional holders of IBB include Citigroup Inc, BNP PARIBAS FINANCIAL MARKETS, Two Sigma Investments, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.